Dubai, United Arab Emirates - Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1 Moody’s / BB+ S&P, both stable), the multinational generic pharmaceutical company, announced the completion of a number of community-driven and employee-centric initiatives on the heels of the company’s annual Global Volunteering Day and the holy month of Ramadan.
“Our Global Volunteering campaign and Ramadan initiatives have always been an opportune time for us at Hikma to support the communities in which we operate, while raising awareness on wide-ranging social and environmental issues,” said Hana Darwazeh Ramadan, VP of Corporate Social Responsibility at Hikma. “We take pride in providing opportunities for our employees to participate in community service activities that give back to our local communities, our people and our environment, creating a shared value for all.”
The following provides a recap of the company’s community service initiatives organised through its Corporate Social Responsibility (CSR) programme. Working with Charities in MENA: During Ramadan, a series of events were held in several countries across the MENA region. Hikma staff members volunteered in various charity activities targeting underprivileged segments of society and participated in multiple functions aimed at building strong relationships among employees.
Global Volunteering Day: In its eleventh year, the company’s annual Global Volunteering Day saw various activities taking place at multiple Hikma locations across the globe. For the duration of the campaign, over 200 Hikma employees participated in community service events geared towards improving the living conditions of local community members; advancing physical and mental wellbeing; delivering food donations; and promoting environmental conservation.
Distributing Meals: Hikma in Algeria collaborated with ‘Al-Shehab’ scouts to arrange an event to distribute food items to more than 54 families in the municipality of Souidania. In Egypt, several Hikma employees delivered Iftar meals for families residing in a disadvantaged district, as well as for patients in three public hospitals: Abu L-Reesh Mounira Children’s Hospital, National Cancer Institute and October 6 University Hospital.
Renovating Homes and Working with Students: Hikma in Jordan partnered with the Royal Health Awareness Society and Tkiyet Um Ali to paint and renovate houses in underprivileged areas in Sahab and Salt, as well as organised health-related events at two public schools. Employees engaged with approximately 400 young students through storytelling, colouring and health-themed classroom games.
Addressing Bullying in Schools and Conservation Efforts: Employees in Egypt addressed school violence and bullying at a rural public school. They interacted with 100 young students through experiential learning and various art activities and games that focused on respect, empathy and setting boundaries. Meanwhile, employees in Saudi Arabia joined an outdoor cleaning initiative, which involved collecting plastic waste from water reserves inside natural caves in efforts to conserve the natural environment.
Helping Families in Need: To help families in need, the US teams volunteered with various local organisations, including a charity house that has been providing families with low-cost accommodation during medical treatments and delivering food donations to local pantries, stocking shelves, preparing produce and moving inventory.
-Ends-
About Hikma
Hikma helps put better health within reach every day for millions of people in more than 50 countries around the world. For more than 40 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a global company with a local presence across the United States (US), the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 8,400 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner in the MENA region, and through our venture capital arm, are helping bring innovative health technologies to people around the world. For more information, please visit: www.hikma.com
Enquiries
Hikma Pharmaceuticals
Dana Alhusseini
Email: Dalhusseini@hikma.com
Tel: +962 6 580 2900
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
